Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Slozem 300mg Capsules

Discontinued
Active Ingredient:
diltiazem hydrochloride
Company:  
Merck See contact details
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Notification of Discontinuation of Slozem® (diltiazem hydrochloride)

{healthcare_pro_orange} For Healthcare Professionals

By the end of February 2020, the following Blister packs 28 capsules will be discontinued: - Slozem 120 mg Capsules (diltiazem hydrochloride) - Slozem 180 mg Capsules (diltiazem hydrochloride) - Slozem 240 mg Capsules (diltiazem hydrochloride) - Slozem 300 mg Capsules (diltiazem hydrochloride)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Merck
Company image
Address
Merck Serono Ltd, 5 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, UK
Telephone
+44 (0)208 818 7200
Fax
+44 (0)208 818 7267
Medical Information Direct Line
+44 (0)208 818 7373
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0)208 818 7274